Global Breast Lesion Localization Market Size, Share, Forecast Report, 2020-2027

Global Breast Lesion Localization Market is expected to hold a value of about USD 560 Million by 2025 and is projected to register a CAGR of 6.8% from 2019 to 2025.
Breast Lesion Localization Market Segmentation

By Type

Wire-Guided Localization: This is the most widely used method for localizing non-palpable breast lesion which uses fluoroscopic guidance. It is considered as the standard localizing method for non-palpable breast lesions. There is an increase in demand for wire-guided localization as it is safe, effective, well established, and cost-effective products.
Radioactive Seed Localization (RSL): RSL is used as an alternative method to wire guide localization. This method used radioactive components to detect the affected cells. The compatibility of RSL in the sentinel lymph node mapping increases the demand for this product.
Non-Radioactive Radar Localization: It is one of the alternative localization methods that use non-radioactive micro-impulse radar technology for surgical guidance.
Magnetic Seed: This method used magnetic traces to localize breast lesions. There is a demand for magnetic seed localizer as it does not require radiation safety procedures and no risk of an allergic reaction.
Others: The segment includes electromagnetic localization and other products.
By Technique

Fine-Needle Aspiration Biopsy: In this most common technique used to localize the nonpalpable or unclear breast lesion in the patient body. There is an increase in demand for this technique owing to the availability of products that this technology and its per.
Core Needle Biopsy: It is the removal of small cells from the patient’s body after the identification of abnormal growth in the affected organ.
Image-Guided Biopsy: In an image-guided biopsy, the biopsy needle is placed through the patient’s skin into an organ of interest using imaging for guidance. Computer tomography and ultrasonography are the two common imaging modalities that are the most used technology that that the demand for this technology.
By Usage

Tumor Identification: Breast lesion localization is an advanced method used in screening and diagnostic of breast images to identify benign and malignant tumors. Breast cancer causes a high incidence of malignant tumors in a woman and which increase the demand for treatment method. The increasing prevalence of breast cancer across the globe is increasing the demand for breast lesion localization products.
Sentinel Lymph Node Identification: Sentinel node is the first lymph lump that gets affected when cancer starts spreading. The identification of lymph nodes is a preoperative procedure performed to remove the primary cancer cells.
By End-User

Diagnostic Centers: Diagnostic centers are estimated to be the largest market in the global breast lesion localization market. The availability of advanced diagnostic methods and skilled professionals across the diagnostics centers increases the market growth.
Hospitals and Clinics: Hospitals and clinics are the primary points for diagnosis and treatment for individuals. The increase in patient visits to hospitals for the diagnosis increases the segmental growth.
Ambulatory Surgical Centers: It is estimated to be the fastest-growing segment owing to the presence of a patient-friendly environment, specialty centers and cost-effective treatment methods that drive segmental growth.

Breast Lesion Localization Market Key Players

• D. Company (US)
• Cianna Medical (US)
• Cook Medical (US)
• Endomagnetics Ltd (UK)
• Health Beacon (Ireland)
• Intramedicalimaging
• Devicor Medical Products, Inc (US)
• Somatex Medical Technologies GmbH (Germany)
• Surgiceye GmbH (Germany)
• Ranfac Corporation (US)